key: cord-0997378-thzxa70o authors: Corti, Carla G.; Seganti, Alessandro; Sanzo, Antonio; Nespoli, Luisa F.; Goletto, Sara; Izzo, Francesca; Zuccotti, Gian Vincenzo; Mannarino, Savina title: Multisystem Inflammatory Syndrome in Children Unmasking Brugada Type 1 Pattern date: 2022-02-16 journal: JACC Case Rep DOI: 10.1016/j.jaccas.2021.12.023 sha: d44345276d20ab63c443e8200707e60b9f454f06 doc_id: 997378 cord_uid: thzxa70o We describe the case of a 14-year-old boy hospitalized for multisystem inflammatory syndrome in children who developed atrial fibrillation during the acute phase and a transient Brugada type 1 pattern in the subacute phase. Eight months later, a provocative test with ajmaline confirmed the suspicion of Brugada syndrome. (Level of Difficulty: Intermediate.) Five days prior to the admission, he had developed fever, nausea, vomiting, and diarrhea. On the day of admission, skin rash and conjunctivitis appeared. The patient had no history of medical illness and had a negative family history for cardiovascular diseases. He practiced competitive sports; previous electrocardiographic (ECG) and stress test results were normal. A Brugada phenocopy (BP) was suspected, given the underlying inflammatory status during hospitalization and the negative family and medical histories. To discriminate between Brugada syndrome (BrS) and BP, the patient was referred to an electrophysiology center. Electrocardiography showed sinus rhythm, QRS fragmentation in D3, and "saddleback" ST-segment elevation in modified precordial leads (MPLs) (Figures 1 and 2) . Electrocardiograms with standard leads and MPLs of his parents and sister To perform a provocative test with ajmaline when Brugada type 1 pattern is elicited in MIS-C to distinguish BP from BrS. To carefully monitor on electrocardiography not only in the acute inflammatory phase of MIS-C but also in the subacute phase and during follow-up to detect Brugada type 1 pattern. were obtained and did not show any abnormal findings. An ajmaline provocation test was proposed and accepted by the patient and his parents. Five minutes after intravenous infusion of ajmaline 1 mg/kg, a Brugada pattern appeared ( Figure 3 ). On admission to the intensive care unit, the patient was hypotensive and tachycardic; the The coved ST-segment elevation seen during the hospitalization of our patient was initially interpreted as a BP. Indeed, he had never had symptoms related to BrS, nor did he have a suspicious family history. At 10-month follow-up, no symptoms, arrhythmias, or syncope was reported. Given the absence of high-risk criteria and symptoms at ambulatory follow-up, genetic testing and lifestyle modifications were indicated. CONCLUSIONS MIS-C may elicit Brugada type 1 pattern during the acute or subacute phase of the disease. In such a condition, the differential diagnosis between true BrS and BP is complex, so that in selected cases with low pretest probability for BrS, pharmacologic challenge could be a way to discriminate an acquired condition from a congenital disease. We suggest careful ECG monitoring not only in the acute inflammatory phase of MIS-C but also in the subacute phase and during postdischarge follow-up. KEY WORDS autonomic system dysregulation, cytokine storm, Brugada phenocopy, Brugada syndrome, multisystem inflammatory syndrome in children Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 Transient type 1 Brugada pattern without ongoing fever during COVID-19 Pneumonia Electrocardiographic changes in children with multisystem inflammation associated with COVID-19 Atrioventricular block in children with multisystem inflammatory syndrome Cardiac autonomic dysfunction in Brugada syndrome Cardiac sodium channel dysfunction in sudden infant death syndrome What role for autonomic dysfunction in Brugada syndrome? Pathophysiological and prognostic implications Brugada phenocopy: mechanisms, diagnosis, and implications Everybody has Brugada syndrome until proven otherwise? Heart Rhythm Brugada-like pattern and myocarditis in a child with multisystem inflammatory syndrome: overlap or differential diagnosis?